Sedana Medical AB (publ) change Certified Adviser from Pareto Securities AB to Erik Penser Bank


Sedana Medical AB (publ) informs today a change of Certified Adviser from Pareto Securities AB to Erik Penser Bank as of January 1st, 2018


For additional information, please contact:

Christer Ahlberg, CEO, Sedana Medical AB

Mobile: +46 70 675 33 30,

E-mail: Christer.ahlberg@sedanamedical.com

Pareto Securities is certified advisor to Sedana Medical.

_________________________

Sedana Medical AB (publ) has developed and sells the medical device AnaConDa, for the administration of volatile anaesthetics to mechanically ventilated patients. A major clinical registration study is currently ongoing to obtain market approval in Europe for inhalation sedation in intensive care units with the pharmaceutical IsoConDa® (isoflurane)

Sedana Medical has direct sales in the Nordic countries, Germany, France and Spain as well as external distributors in the rest of Europe, Middle East, Canada, Australia and South Korea. The company headquarters are based in Stockholm, Sweden with R&D operations in Ireland.

Tags:

About Us

Sedana Medical AB (publ) has developed and sells the medical device AnaConDa, for the administration of volatile anaesthetics to mechanically ventilated patients.A major clinical registration study is currently ongoing to obtain market approval in Europe for inhalation sedation in intensive care units with the pharmaceutical IsoConDa® (isoflurane) Sedana Medical has direct sales in the Nordic countries, Germany, France and Spain as well as external distributors in the rest of Europe, Middle East, Canada, Australia and South Korea. The company headquarters are based in Stockholm, Sweden with R&D operations in Ireland.

Subscribe

Documents & Links